AChE Inhibition Study for Alzheimer's Disease Treatment: An In-silico Study

Main Article Content

Mohd Adnan Kausar

Abstract

Alzheimer's disease (AD) is the most common form of dementia associated with plaques and tangles in the brain. Several acetylcholinesterase inhibitors have been clinically used to delay or halt the progression of the disease. Solanadine (Snd) and gamma solamargine (Gsm) have been shown to inhibit acetylcholinesterase (AChE). The current study attempts to describe the molecular interactions between human brain AChE and inhibitors Snd and Gsm. The free energy of binding and estimated dissociation constant (Ki) for the 'Snd-AChE Catalytic Anionic site (CAS)-interaction' were determined to be –9.51 kcal/mol and 107.54 nM, respectively and the free energy of binding and estimated Ki for the 'Gsm -AChE CAS-interaction' were determined to be – 8.64 kcal/mol and 463.88 nM, respectively. Hydrophobic interactions, polar interactions, and hydrogen bonding play an important role in the correct positioning of Snd within the 'catalytic site' of AChE to permit docking, while hydrophobic interactions and polar interactions play a significant role in the correct positioning of Gsm within the 'catalytic site' of AChE to permit docking. It is hoped that the information provided in this study will help in the design of AChE-inhibitors as anti-Alzheimer agents.

Keywords:
AChE, auto dock tools, Interactions, binding energy.

Article Details

How to Cite
Kausar, M. A. (2020). AChE Inhibition Study for Alzheimer’s Disease Treatment: An In-silico Study. Journal of Pharmaceutical Research International, 32(24), 119-125. https://doi.org/10.9734/jpri/2020/v32i2430817
Section
Original Research Article

References

Ahmed MQ, Alenazi FHH, Fazaludeen MF, Shahid SMA, Kausar MA. Pathology and management of alzheimer’s disease: A review. International Journal of Pharmaceutical Research and Allied Sciences (IJPRAS). 2018;7(2):30-42.

Angelopoulou E, Paudel YN, Shaikh MF, Piperi C. Flotillin: A Promising Biomarker for Alzheimer's Disease. J Pers Med. 2020; 10(2):20.

Shukla R, Singh TR. Virtual screening, pharmacokinetics, molecular dynamics and binding free energy analysis for small natural molecules against cyclin-dependent kinase 5 for Alzheimer's disease. J Biomol Struct Dyn. 2020;38(1): 248-262.

El Haj M, Roche J, Gallouj K, Gandolphe MC. Autobiographical memory compromise in alzheimer's disease: A cognitive and clinical overview. Geriatr Psychol Neuropsychiatr Vieil. 2017;15:443-451.

Azhar A, Ashraf GM, Zia Q, Ansari SA, Perveen A, Hafeez A, Saeed M, Kamal MA, Alexiou A, Ganash M, Yarla NS, Baeesa SS, Alfiky MM, Bajouh OS. Frontier view on nanotechnological strategies for neuro-therapy. Curr Drug Metab. 2018;19(7):596-604.

Shahid SMA, Kuddus M, Ahmed MQ, Saleem M, Kausar MA, Khalid MA, Alghassab TA, Acar T, Alenazi FSH. In silico approach to discover the role of metals for the treatment of Alzheimer’s disease amyloid-beta (Aβ) peptide. Biochem. Cell. Arch. 2018;18(1):629- 635.

Lazarevic-Pasti T, Leskovac A, Momic T, Petrovic S, Vasic V. Modulators of acetylcholinesterase activity: From alzheimer's disease to anti-cancer drugs. Curr Med Chem. 2017;24:3283-3309.

Shaikh S, Ahmad SS, Ansari MA, et al. Prediction of comparative inhibition efficiency for a novel natural ligand, galangin against human brain acetylcholinesterase, butyrylcholinesterase and 5-lipoxygenase: A neuroinformatics study. CNS Neurol Disord Drug Targets. 2014;13(3):452-9.

Colović MB, Krstić DZ, Lazarević-Pašti TD, Bondžić AM, Vasić VM. Acetylcholinesterase inhibitors: pharmacology and toxicology. Curr Neuropharmacol. 2013;11(3):315-35.

Du X, Wang X, Geng M. Alzheimer's disease hypothesis and related therapies. Transl Neurodegener. 2018;7:2.

Anand P, Singh B. A review on cholinesterase inhibitors for Alzheimer's disease. Archives of Pharmacal Research. 2013;36(4):375–399.

Patil P, Thakur A, Sharma A, Flora SJS. Natural products and their derivatives as multifunctional ligands against Alzheimer's disease. Drug Dev Res. 2020;81(2):165-183.

Thapa S, Lv M, Xu H. Acetylcholinesterase: A Primary target for drugs and insecticides. Mini Rev Med Chem. 2017;17(17):1665-1676.

Taylor P, Radić Z. The cholinesterases: From genes to proteins. Annu Rev Pharmacol Toxicol. 1994;34:281- 320.

Ahmad SS, Sinha M, Ahmad K, Khalid M, Choi I. Study of Caspase 8 Inhibition for the management of alzheimer's disease: A molecular docking and dynamics simulation. Molecules. 2020;25(9):2071.

Alam A, Shaikh S, Ahmad SS, et al. Molecular interaction of human brain acetylcholinesterase with a natural inhibitor huperzine-B: An enzoinformatics approach. CNS Neurol Disord Drug Targets. 2014;13(3):487-90.

Baig MH, Ahmad K, Roy S, et al. Computer aided drug design: Success and limitations. Curr Pharm Des. 2016;22(5): 572-81.

Nikolic NC, Stankovic MZ. Solanidine hydrolytic extraction and separation from the potato (Solanum tuberosum L.) vines by using solid-liquid-liquid systems. J Agric Food Chem. 2003;51(7): 1845-9.

Bushway RJ, Savage SA, Ferguson BS. Inhibition of acetyl cholinesterase by solanaceous glycoalkaloids and alkaloids. American Potato Journal.1987;64:409–413.

Everist SL. Poisonous plants of Australia. Angus and Robertson; 1974.

Friedman M, Henika PR, Mackey BE. Effect of feeding solanidine, solasodine and tomatidine to non-pregnant and pregnant mice. Food Chem Toxicol. 2003; 41(1):61-71.

Kuiper-Goodman T, Nawrot P. Solanine and chaconine. World Health Organization: Geneva, Switzerland; 1993.

Harvey MH, McMillan M, Morgan MR, Chan HW. Solanidine is present in sera of healthy individuals and in amounts dependent on their dietary potato consumption. Hum Toxicol. 1985;4(2):187-94.

Sun Y, Zhao Y, Wang L, Lou HX, Cheng AX. Cloning and expression analysis of squalene synthase, a key enzyme involved in antifungal steroidal glycoalkaloids biosynthesis from Solanum nigrum. Drug Discov Ther. 2012;6(5):242-8.

Saeed M, Baig MH, Bajpai P, Srivastava AK, Ahmad K, Mustafa H. Predicted binding of certain antifilarial compounds with glutathione-S-transferase of human filariids. Bioinformation. 2013;9(5):233-7. DOI: 10.6026/97320630009233

Daina A, Michielin O, Zoete V. SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7:42717.

Böhm HJ. The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure. J Comput Aided Mol Des. 1994; 8(3):243-56.

Kuppusamy A, Arumugam M, George S. Combining in silico and In vitro approaches to evaluate the acetylcholinesterase inhibitory profile of some commercially available flavonoids in the management of Alzheimer's disease. Int J Biol Macromol. 2017; 95:199-203.

Steiner T, Koellner G. Hydrogen bonds with pi-acceptors in proteins: Frequencies and role in stabilizing local 3D structures. J Mol Biol. 2001;305(3):535-57.